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Background
Th e timing and indications for surgical intervention to 
prevent systemic embolism in infective endocarditis (IE) 
remain controversial. Th is trial compares clinical 
outcomes of early surgery and conventional treatment in 
patients with IE.
Methods
Objective: To determine the eﬀ ect of early surgery 
(<48  hours) to decrease the rate of death or embolic 
events as compared with conventional treatment for IE.
Design: Prospective randomized trial.
Setting: Two academic medical centers in Korea.
Subjects: Adult patients with left-sided, native-valve IE 
and a high risk of embolism.
Intervention: Valve repair or replacement with removal of 
vegetation within 48 hours of random assignment versus 
no early surgery.
Outcomes: Composite primary endpoint of in-hospital 
death and embolic events occurring within 6 weeks after 
random assignment. Secondary endpoints, at 6 months, 
included death from any cause, embolic events, 
recurrence of IE, and repeat hospitalization due to the 
development of congestive heart failure.
Results
Th irty-seven patients were assigned to the early-surgery 
group (<48  hours), whereas 39 were assigned to conven-
tional therapy. Of the 39 randomly assigned to conven tional 
therapy, 27 patients (77%) underwent surgery during the 
initial hospitalization and three during follow-up. One 
patient (3%) in the early-surgery group and nine (23%) in 
the conventional-treatment group reached the primary 
endpoint (hazard ratio (HR) 0.10, 95% conﬁ  dence interval 
(CI) 0.01 to 0.82; P  =  0.03). Th ere was no signiﬁ cant 
diﬀ erence in all-cause mortality at 6 months in the early-
surgery and conventional-treatment groups (3% and 5%, 
respectively; HR 0.51, 95% CI 0.05 to 5.66; P = 0.59). Th e 
rates of the composite endpoint of death from any cause, 
embolic events, or recurrence of IE at 6 months were 3% 
in the early-surgery group and 28% in the conventional-
treatment group (HR 0.08, 95% CI 0.01 to 0.65; P = 0.02).
Conclusions
Early surgery in patients with IE and large vegetations 
signiﬁ cantly reduced the composite endpoint of death 
from any cause and embolic events by eﬀ ectively 
decreasing the risk of systemic embolism.
Commentary
Even with recent advancement in modern health science, 
infective endocarditis (IE) remains a disease associated 
with signiﬁ cant morbidity and mortality [1]. Its incidence 
increased from 5 to 7.9 cases per 100,000 person-years in 
Minnesota from 1970 to 2007 [2]. Th e role of surgical 
intervention is increasing, and better outcomes are being 
realized [3]. Current guidelines of the American Heart 
Association (AHA) favor early surgical intervention in 
heart failure, but indications for surgery to prevent 
systemic embolization are not clear [4,5]. Although the 
European Society of Cardiology has strongly recom men-
ded urgent surgery (within a few days) for a vegetation 
size of greater than 10  mm in an eﬀ ort to prevent 
systemic embolization, evidence to support this aggres-
sive approach is based mainly on observational studies 
[6,7]. Several randomized control trials (RCTs) have been 
conducted to determine choice and duration of 
antibiotics for IE, but no RCT regarding timing and 
indication of surgery is available. Early surgery may be 
beneﬁ cial since most emboli occur during the ﬁ rst week 
following the start of therapy, and the majority of these 
are cerebral emboli, which lead to poor outcomes [8]. © 2010 BioMed Central Ltd
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Th is study was designed to address the role of timing of 
surgery in the prevention of systemic embolization in 
patients without heart failure but with large vegetations 
(>10 mm).
All 39 patients in early intervention group underwent 
surgery, whereas only 30 (77%) of the 39 patients in the 
conservative group had surgery, presumably because it 
was felt to be indicated. In the conservative group, eight 
(21%) had indications for urgent surgery (mean time of 
6.5  days after random assignment), and 22 (56%) had 
elective surgery after 2 weeks because of left ventricular 
dysfunction. Th e early-surgery group had no embolic 
events, whereas the conservative group had eight (21%) 
cases of documented systemic embolization (0% versus 
21%, P = 0.005). All embolic events occurred during the 
ﬁ rst 6  weeks (primary endpoint). In both groups, there 
was no signiﬁ cant diﬀ erence in mortality at 6 weeks (3% 
versus 5%, P = 1.00) or 6 months (secondary endpoint). 
Th e results of this study suggest that early surgical 
intervention signiﬁ cantly reduces the incidence of major 
embolic events without altering other short- and long-
term endpoints. Th is study is important because it is the 
ﬁ rst randomized clinical trial to address a subgroup of 
patients with large vegetations without heart failure.
Th e signiﬁ cance of this study lies in the low pre-existing 
morbidity of the patients and the potential for real 
improvement in quality of life if signiﬁ cant embolization 
is avoided. Given the ﬁ ndings of the study, the AHA may 
modify its recommendations on the treatment of patients 
with IE and large vegetations. Interestingly, the overall 
mortality was lower in this study than the other 
observational studies of IE (5% versus 27%) [9]. Th is 
lower mortality may be related to strict inclusion criteria 
and excluding patients with complicated IE. Another 
possibility for the observed lower mortality in all subjects 
may be related to low incidence of Staphylococcal 
infection, an important risk factor for death in IE [10,11]. 
Th is study does not include patients with prosthetic 
valve, major stroke, and right-sided endocarditis, and this 
makes its recommendations limited in scope. Further-
more, though it is an RCT, it is not blinded, and this can 
cause ascertainment bias. Th us, it is diﬃ  cult to generalize 
these results to all patients presenting with IE and large 
vegetations.
Although this is a small RCT, it signals a new era in 
conducting RCTs to determine optimal surgical 
approaches for patients with IE. Interestingly, in 2008, a 
larger RCT testing optimal timing of surgery for IE was 
also initiated (NCT00624091) [12]. Th at study is ongoing 
and is testing the role of timing of surgery for other 
indications, such as prosthetic heart valves and 
complicated IE. It will be interesting to see whether early 
surgery remains superior for preventing complications in 
this larger diverse group of patients.
Recommendation
Early surgical repair of pat ients with left-sided IE and 
large vegetations results in a markedly reduced incidence 
of long-term embolic complications without altering 
mortality as compared with using antibiotics alone and 
elective surgical repair.
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